Altamira Therapeutics CYTOF
OTC CYTOF
$0.09 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Altamira Therapeutics Ltd. (CYTOF) Receivables (2018 - 2023)

Updated

Altamira Therapeutics (CYTOF) recorded Receivables of $35,382 in Q2 2023, down 92.3% from $461,037 a year earlier.

Analysis

Altamira Therapeutics Ltd. (CYTOF) Receivables (2018 - 2023) Analysis & Trends

At the end of FY2022, Altamira Therapeutics reported Receivables of $791,504, down 45.6% from FY2021.

  • Annual Receivables has a four-year compound annual growth rate of 25.2% (FY2018 to FY2022).
  • Across earlier years, Receivables came in at $1.46 million in FY2021, $89,445 in FY2020 (-73.6%), $338,781 in FY2019 (+5.2%) and $321,923 in FY2018.
  • Quarterly Receivables has ranged from $7,053 in Q4 2022 to $1.46 million in Q4 2021 over the past five years.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 35,381.58
Jan 1, 2023 7,053.00
Dec 31, 2022 826,257.76
Jun 30, 2022 465,356.62
Dec 31, 2021 1.47 Mn
Jun 30, 2021 152,321.64
Dec 31, 2020 91,722.82
Jun 30, 2020 158,791.86
Dec 31, 2019 346,157.98
Jun 30, 2019 308,507.65
Dec 31, 2018 325,715.74
API Access

Altamira Therapeutics Ltd. Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=CYTOF&period=max&api_key=YOUR_API_KEY